NEW YORK, NY / ACCESSWIRE / February 14, 2020 / Pomerantz LLP announce that a class action lawsuit has been filed against Trulieve Corporation (“Trulieve” or the “Company”) (TCNNF) and certain of its officers. The class action, filed in United States District Court for the Eastern District of New York, and docketed under 20-cv-00775, is on behalf of a class consisting of investors who purchased or otherwise acquired Trulieve securities between September 25, 2018 and December 17, 2019, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
If you are a shareholder who purchased Trulieve securities during the class period, you have until February 28, 2020 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at firstname.lastname@example.org or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address,